Opportunistic infections usually aggravate the clinical condition of HIV-infected patients; of these, parasites play an important role as most common causes of morbidity and mortality, especially in those who are severely immunosuppressed [1] . On the other hand, Blastocystis is a ubiquitous emerging parasite with unresolved controversy over its pathogenicity; besides, it remains one of the most frequent human intestinal parasites with zoonotic potential. This microorganism has been divided into numerous subtypes (ST), nine of which have been identified in immunocompromised and non immunocompromised human carriers with or without intestinal disorders [2, 3] .
Twenty-seven asymptomatic adult patients confirmed with HIV/AIDS one or two years ago, who have CD4+ T-lymphocyte count >200 cells/mm 3 , under highly active antiretroviral therapy (HAART), and are being attended in the HIV/AIDS Clinic of the Hospital General "Dr. Manuel Gea Gonzalez" for their periodic check-up, were recruited for search of opportunistic intestinal parasites and Blastocystis ST infection; a descriptive cohort study over a 9-month period (June 2011 to March 2012) was used. The Ethics and Research Committee of our hospital approved the study and informed consent was obtained from each patient before recruitment. For baseline, three faecal specimens were requested to each participant, and four cross-sectional analyses with serial stool samples at one, three, six and nine months were performed. Coproparasitoscopic analysis was performed using Faust´s technique and microscopic observation for search of protozoa cysts and helminth ova was done. Non-concentrated smears were airdried; methanol fixed and stained using Kinyoun acidfast to detect Cryptosporidium spp., Cystoisospora belli and Cyclospora cayetanensis according to Kurniawan et al [1] . Aliquots were processed by PCR for Blastocystis diagnosis and identification of ST. For this, stool DNA was extracted and PCR performed according to Jimenez-Gonzalez et al. [4] and Santin et al. [5] ; some amplicons were purified and submitted to sequence with a commercial supplier. All sequences were subjected to BLAST search in the GenBank database; multiple alignments were executed and a phylogenetic inference by the neighbor-joining method was performed. Finally, to investigate the association between some variables, a χ 2 test was used. P-value <0.05 was considered significant (Epi-Info version 6). Along the study patients who were positive to pathogen parasites were treated conventionally with trimethoprim-sulfamethoxazole for intestinal coccidia and nitazoxanide for protozoa; 15 days after treatment serial samples were analysed to corroborate the efficiency to therapy; asymptomatic patients to Blastocystis did not receive therapy.
A total of 21 male and 6 female with a mean age and standard deviation of 39±17 years, were recruited. Table 1 shows the positive coproparasitoscopic and PCR results along the study for all participants; eight patients (30%) were negative at the follow-up measurement, while the rest harboured commensal protozoa or by some parasites. In general, participants exhibited one type of infection, while only two presented co-infections (patients 22 and 25). Blastocystis was present in 30%, Endolimax nana and intestinal coccidia in 22%; other protozoa were less frequent and no helminths were observed. The only statistical association found was between diarrhoea and presence of intestinal coccidia (P=0.004). Half of Blastocystis carriers were infected with ST1 and ST3 respectively. All patients infected with coccidia or with Giardia lamblia presented intestinal alterations as diarrhoea, abdominal pain and bloating; only two patients (7 and 25) infected with Blastocystis showed irritable bowel syndrome according to the Rome III criteria [6] ; symptoms declined when anti-parasitic therapy was applied. Interestingly, during the second cross-sectional analysis, patient 17 was symptomatic and presented co-infection with G. lamblia, E. coli and Blastocystis, last only identified by PCR; treatment was supplied and 15 days later no parasites were identified and symptoms disappeared, but in the next cross-sectional analysis, Blastocystis of the similar ST (ST1) was present together with E. coli, probably due to deficient hygienic habits, as suggested by the persistence of Entamoeba coli; the patient was asymptomatic. The phylogenetic tree (Figure 1 ) revealed the presence of ten different clades that corresponded exactly to ST1 to 10 according to Santin et al. [5] and our sequences were grouped in the ST1 and ST3 clades. Although, in present work, controversy remains over the pathogenic potential of Blastocystis ST; according to Stensvold et al. [3] , it is possible that differences in clinical outcome of Blastocystis infection are related to genetic differences on the subtype-or strain-level.
We can conclude that i) Blastocystis ST1 and ST3 were the most frequent parasites identified; ii) Blastocystis ST1 is potentially capable of reinfecting the same carrier in at least a three-month period; iii) symptomatic cases should be submitted to PCR in order to increase sensitivity in the detection of Blastocystis, especially in immunocompromised patients; intestinal coccidia were the most frequent parasites after Blastocystis; iv) other molecular markers for Blastocystis ST should be studied to elucidate the complexity of this heterogeneous genus and its role in human disease.
